Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 445

BillFederalSenateIn Committee
Mainstreaming Addiction Treatment Act of 2021
About This Bill
Committee
Latest Action · February 25, 2021
Referred to the Committee on Health, Education, Labor, and Pensions.
Congress
117th (2021–2023)
Introduced
February 25, 2021
Cosponsors (28)
19D 7R
View PDF ↗

Summary

Highlight any text to annotate
Mainstreaming Addiction Treatment Act of 2021 This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration (DEA) to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment). Further, a community health aide or community health practitioner may dispense certain narcotic drugs for maintenance or detoxification treatment without registering with the DEA if the drug is prescribed by a health care practitioner through telemedicine. It preempts state laws related to licensure for this activity. The bill also directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.